Abstract
Using a conjoint analysis based on cases in Japan, this study attempts to identify a preferable social strategic combination of “Who is vaccinated, who is not, who waits.” The analysis shows that the most desirable choice is a “wait-and-see” strategy, allowing for a risk assessment of side effects. We also find that subjects who recalled blood relatives as their familiar entities tend to prefer a “wait-and-see” strategy for themselves and their blood relatives.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This research was supported by Grant-in-Aid for Young Scientists 19K13615.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Kwansei Gakuin University Committee for Regulations for Behavioral Research with Human Participants issued a decision dated March 17, 2021 to approve the "Investigation of Relationship among Partisanship, Political Knowledge and COVID-19".
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
This work was supported by Grant-in-Aid for Young Scientists 19K13615.
Paper in collection COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv
The Chan Zuckerberg Initiative, Cold Spring Harbor Laboratory, the Sergey Brin Family Foundation, California Institute of Technology, Centre National de la Recherche Scientifique, Fred Hutchinson Cancer Center, Imperial College London, Massachusetts Institute of Technology, Stanford University, University of Washington, and Vrije Universiteit Amsterdam.